PropertyValue
?:abstract
  • SARS-CoV-2-infected inpatients who are admitted to a noncritical care medical ward require a standardized approach that is based on evidence if available, and effective supportive and respiratory care. Outcomes are better when patients receive standardized care, in special COVID-19 wards in the hospital, from clinical teams with expertise. Available evidence and guidelines should be continuously appraised and integrated into clinical protocols for all domains of treatment, including isolation, and personal protective measures, pharmacologic therapy, and transitions of care. Inpatient pharmacologic therapy at this time consists primarily of dexamethasone and remdesivir, along with thromboprophylaxis, given the coagulopathy associated with COVID-19. This article summarizes current practices in our organization.
is ?:annotates of
?:creator
?:doi
  • 10.3949/ccjm.87a.ccc064
?:doi
?:journal
  • Cleveland_Clinic_journal_of_medicine
?:license
  • unk
?:pmid
?:pmid
  • 33144286.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • The hospitalized patient with COVID-19 on the medical ward: Cleveland Clinic approach to management.
?:type
?:year
  • 2020-11-03

Metadata

Anon_0  
expand all